⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL387990 | 1.00 | — | — | |
| SCHEMBL386778 | 0.83 | — | — | |
| SCHEMBL386779 | 0.83 | — | — | |
| SCHEMBL386870 | 0.81 | — | — | |
| SCHEMBL387806 | 0.79 | TSHR (0.42) | — | |
| SCHEMBL385643 | 0.79 | TSHR (0.42) | — | |
| SCHEMBL387658 | 0.75 | — | — | |
| SCHEMBL10360070 | 0.74 | — | — | |
| SCHEMBL387500 | 0.72 | — | — | |
| SCHEMBL10359796 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | disclosed |
| US-8101650-B2 | Method for treating a immunology-related disease | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8067396-B2 | Amino alcohol compounds or phosphonic acid derivatives thereof | SANKYO COMPANY, LIMITED (JP) | 2011-11-29 | — | — | US | disclosed |
| US-20100035842-A1 | Amino alcohol compounds or phosphonic acid derivatives thereof | SANKYO COMPANY, LIMITED (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090326038-A1 | Method for treating a immunology-related disease | SANKYO COMPANY, LIMITED (JP) | 2009-12-31 | — | — | US | disclosed |
| US-7638551-B2 | Amino alcohol compounds or phosphonic acid derivatives thereof | SANKYO COMPANY, LIMITED (JP) | 2009-12-29 | — | — | US | disclosed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | disclosed |
| EP-2123149-A2 | Oilseed brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2009-11-25 | — | — | EP | disclosed |
| EP-1471054-B1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | DAIICHI SANKYO CO LTD (JP) | 2009-07-01 | — | — | EP | disclosed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | disclosed |
| EP-0853874-A1 | Oilseed brassica containing an improved fertility restorer gene for ogura cyptoplasmic male sterility | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1998-07-22 | — | — | EP | disclosed |
| WO-1998027806-A1 | OILSEED BRASSICA CONTAINING AN IMPROVED FERTILITY RESTORER GENE FOR OGURA CYTOPLASMIC MALE STERILITY | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 1998-07-02 | — | — | WO | disclosed |
| EP-0192242-B1 | SUBSTITUTED AMINOPHENYLUREA DERIVATIVES | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1990-11-07 | — | — | EP | disclosed |
| US-4803223-A | ANTITUMOR AGENTS | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1989-02-07 | — | — | US | disclosed |
| EP-0192242-A1 | Substituted aminophenylurea derivatives | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1986-08-27 | — | — | EP | disclosed |
| US-4276290-A | VETERINARY MEDICINE | ROHM AND HAAS COMPANY (US) | 1981-06-30 | — | — | US | disclosed |
| US-4183921-A | TREATMENT OF INTESTINAL PARASITES IN MAMMALS AND BIRDS | ROHM AND HAAS COMPANY (US) | 1980-01-15 | — | — | US | disclosed |
| US-4170648-A | Phosphonothioureide anthelmintics | ROHM AND HAAS COMPANY (US) | 1979-10-09 | — | — | US | disclosed |
| US-4086336-A | Phosphonothioureide anthelmintics | ROHM AND HAAS COMPANY (US) | 1978-04-25 | — | — | US | disclosed |
| US-4076809-A | Phosphonoureide and phosphonothioureide anthelmintics | ROHM AND HAAS COMPANY (US) | 1978-02-28 | — | — | US | disclosed |